Mumbai, Technology-driven healthcare solutions provider Take Solutions Limited on Friday announced its strategic foray into India’s burgeoning longevity and anti-ageing market, leveraging its expertise in clinical research, life sciences and regulatory processes.
The company said the initiative aims to build a scalable platform encompassing consumer health products and digital wellness solutions, marking a significant diversification from its core offerings.
The company also plans to develop science-backed nutraceuticals, biohacking-focused products, and predictive digital tools that can help consumers track and optimise metabolic health, sleep, cognition, and biological ageing, a company statement said.
This approach is intended to create a differentiated offering in a market that is still underpenetrated, but increasingly attractive to investors due to its repeat-purchase potential and margin profile, it added.
“Through this initiative, we aim to build a diversified revenue mix across consumer products, services, and digital platforms, while leveraging our core strengths in healthcare and regulatory execution to deliver solutions that are both scalable and clinically credible,” said Parmeshvar Dhangare, Director of Take Solutions Limited.
India’s preventive healthcare market was valued at USD 197 billion by 2025, reflecting a broader shift from reactive care toward prevention, monitoring, and early intervention, Take Solutions said.
Within this landscape, the India anti-ageing supplements market is projected to grow from USD 168.6 million in 2025 to USD 341.4 million by 2033 at a CAGR of 9.5 per cent, while the India anti-ageing services market was valued at USD 567.5 million in 2024 to USD 1,059.6 million by 2035 at a CAGR of 5.8 per cent, it said.
